Mark Edward Stella is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on innovative dosage forms that enhance the effectiveness and usability of medications.

Latest Patents

Among his latest patents, Stella has developed an "Extended Relief Dosage Form." This dosage form features a first portion that can provide immediate release of a pain reliever, such as naproxen or naproxen sodium. The second portion is designed for extended release and may include pseudoephedrine or dextromethorphan, along with a stabilizing agent. This formulation is capable of maintaining a therapeutically effective amount of the active ingredients for at least eight hours. Another significant patent is the "Effervescent Dosage Form," which is a chewable formulation containing a pH neutralization agent, an acid, and an effervescent agent. This innovative dosage form can also include simethicone, a sweetener, and a lubricant, enhancing its usability and effectiveness.

Career Highlights

Mark Edward Stella is currently associated with The Procter & Gamble Company, where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also advanced the field of medication delivery systems.

Collaborations

Stella has collaborated with notable coworkers, including John Richard Entwisle and Jason William Newlon. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Mark Edward Stella's contributions to pharmaceutical innovations, particularly in dosage forms, highlight his role as a key inventor in the industry. His patents reflect a commitment to improving medication delivery and patient care.

This text is generated by artificial intelligence and may not be accurate.